Pfizer to Sponsor Large Celebrex Trial
114059
Pfizer Inc. said on Monday it plans to  sponsor a major clinical study to further assess the  cardiovascular safety of its arthritis drug Celebrex following  the withdrawal of Merck & Co.'s Vioxx, a drug in the same  class.
177782
A U.S. consumer group on Monday accused Pfizer Inc. of burying a study suggesting its painkiller Celebrex boosts the risk of heart attack and stroke, a claim the No. 1 drug maker has denied.
30183
NEW YORK  - US drug giant Pfizer said it will stop advertising painkiller Celebrex after a trial indicated a heart-attack risk at high doses, but vowed to carry on sales.
481067
Pharmaceutical giant Pfizer Inc. will announce plans for a large-scale clinical trial of the ability of blockbuster drug Celebrex to prevent heart attacks and strokes in patients with cardiovascular disease, the Wall Street Journal reported on Monday.
422768
Pfizer reaffirmed its commitment today to Celebrex, its blockbuster prescription medication for pain and inflammation from arthritis.
511798
A government-sponsored trial of Pfizer Inc.'s  blockbuster arthritis drug Celebrex was halted after patients taking the medicine had more than twice as many heart attacks as patients taking a placebo, the company said on Friday.
688234
NEW YORK -- Drug maker Pfizer said yesterday it would immediately stop advertising its best-selling arthritis pain reliever Celebrex to consumers after a study showed high doses of it were associated with an increased heart attack risk.
186524
A government-sponsored trial of Pfizer  Inc.'s PFE.N blockbuster arthritis drug Celebrex was halted  after patients taking the medicine had more than twice as many  heart attacks as patients taking a placebo, the company said on  Friday.
101354
A day after Whitehouse Station-based Merck abruptly withdrew from the market Vioxx, its blockbuster arthritis drug, Pfizer yesterday moved to promote Celebrex, its competing medicine.
635918
No. 1 drugmaker to end marketing push after study points to higher risk of heart attack, stroke. NEW YORK (CNN) - Under pressure from regulators, Pfizer has agreed to limit advertising of Celebrex after a
745709
At a research and development meeting for analysts on Nov. 30, Pfizer (PFE ) stayed on message all day long. Despite questions about possible safety issues with arthritis pain medication Celebrex, patent challenges
638372
Pfizer Inc. on Monday said a major new trial will test whether its popular Celebrex arthritis drug increases the risk of heart attacks, as seen with Merck and Co.
252263
Pfizer Inc. on Friday said patients taking its blockbuster arthritis drug Celebrex in a long-term cancer-prevention trial had more than twice the number of fatal or non-fatal heart attacks as those taking a placebo.
143159
Some analysts are betting Pfizer Inc.  PFE.N won't have to withdraw its arthritis drug Celebrex but  they do expect sales to fall after a study of the drug in  cancer patients showed it increased the risk of heart attacks.
698387
FRIDAY, Dec. 17 (HealthDayNews) -- Pfizer Inc. said Friday that a study of its popular pain drug Celebrex in cancer patients had found an apparent increased risk of heart attack and other cardiovascular problems.
336646
US drug giant Pfizer has said a trial had found a sharp rise in heart attacks for patients using its Celebrex arthritis and pain medicine but it would not immediately withdraw the treatment.
493704
Pfizer is pulling its radio, TV, newspaper and magazine advertising for Celebrex in the wake of a study that links high doses of the popular arthritis to an increased risk of heart attack, but the company plans to keep Celebrex on the market.